2 active not recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 2 |
Follow Hypothalamic Neoplasms: new trials by email Literature Review of Hypothalamic Neoplasms trials Research Report on Hypothalamic Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity Phentermine / Topiramate Extended Release Oral Capsule [Qsymia], Placebo - Hypothalamic Obesity, Hypothalamic Tumor | Phase 2 | Active not recruiting | Seattle Children's Hospital | 24 | 2025-03-01 | 2026-10-16 |
| Enhancement of Neurocognitive Functions by Hippocampal Sparing Radiotherapy Radiation according to indication with hippocampal sparing, Radiation according to indication without hippocampal protection - Radiation of Neurocranial Region | Phase 2 | Active not recruiting | University of Erlangen-Nürnberg Medical School | 150 | 2013-03-01 | 2026-10-27 |
Brain Neoplasms (1) · Craniopharyngioma (1) · Meningioma (1) · Pituitary Neoplasms (1) · Sexual Infantilism (1) · Small Cell Lung Carcinoma (1)
Brain Diseases (2) · Central Nervous System Diseases (2) · Central Nervous System Neoplasms (2) · Endocrine System Diseases (2) · Hypothalamic Diseases (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Nerve Tissue (2) · Nervous System Diseases (2) · Nervous System Neoplasms (2) · Supratentorial Neoplasms (2) · Brain Neoplasms (1) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1)
Phentermine (1) · Qsymia (1)
Seattle Children's Hospital (1) · University of Erlangen-Nürnberg Medical School (1)
Germany (1) · United States (1)
Christian L Roth, MD (1) · Rainer Fietkau, MD (1) · Shana E McCormack, MD (1)